Current and emerging treatment options for uveal melanoma

Código QR

Current and emerging treatment options for uveal melanoma

Patricia Rusa Pereira,1 Alexandre Nakao Odashiro,2 Li-Anne Lim,1 Cristina Miyamoto,1 Paula L Blanco,4 Macanori Odashiro,3 Shawn Maloney,1 Dominique F De Souza,1 Miguel N Burnier Jr1 1The Henry C Witelson Ocular Pathology Laboratory, McGill University, Montreal, QC, Canada; 2Department of Pathology a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pereira PR, Odashiro AN, Lim L, Miyamoto C, Blanco PL, Odashiro M, Maloney S, De Souza DF, Burnier Jr MN
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/833383240330450a8440b68616be1d4e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Blood Biomarkers of Uveal Melanoma: Current Perspectives
por: Bande Rodríguez MF, et al.
Publicado: (2020)

Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses
por: Aaberg Jr TM, et al.
Publicado: (2014)

Birdshot uveitis: current and emerging treatment options
por: Menezo V, et al.
Publicado: (2013)

Rapid growth of an orbital hemangiopericytoma with atypical histopathological findings
por: Pacheco LF, et al.
Publicado: (2013)

Posterior uveal melanoma in adolescents and children: current perspectives
por: Fry MV, et al.
Publicado: (2018)

Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland
por: Samir Aziz, et al.
Publicado: (2008)

Current and emerging treatment options for myopic choroidal neovascularization
por: El Matri L, et al.
Publicado: (2015)

The Economic Value of MR-Imaging for Uveal Melanoma
por: Grech Fonk L, et al.
Publicado: (2020)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi M, et al.
Publicado: (2013)

Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
por: Shah NV, et al.
Publicado: (2013)

Isolated posterior uveal effusion: expanding the spectrum of the uveal effusion syndrome
por: Pautler SE, et al.
Publicado: (2014)

Uveal melanoma: epidemiology, etiology, and treatment of primary disease
por: Krantz BA, et al.
Publicado: (2017)

Current options for the treatment of optic neuritis
por: Pula JH, et al.
Publicado: (2012)

Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review
por: Shah NV, et al.
Publicado: (2012)

Emerging treatment options for meibomian gland dysfunction
por: Qiao J, et al.
Publicado: (2013)

Choroidal findings in idiopathic uveal effusion syndrome
por: Harada T, et al.
Publicado: (2011)

An emerging treatment option for glaucoma: Rho kinase inhibitors
por: Wang SK, et al.
Publicado: (2014)

Presbyopia – A Review of Current Treatment Options and Emerging Therapies
por: Katz JA, et al.
Publicado: (2021)

Combination of oridonin and TRAIL induces apoptosis in uveal melanoma cells by upregulating DR5
por: Xin Hua, et al.
Publicado: (2021)

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
por: Brewington BY, et al.
Publicado: (2018)

Early experiences of planning stereotactic radiosurgery using 3D printed models of eyes with uveal melanomas
por: Furdová A, et al.
Publicado: (2017)

Proliferative vitreoretinopathy: current and emerging treatments
por: Sadaka A, et al.
Publicado: (2012)

Meridional lenticular astigmatism associated with bilateral concurrent uveal metastases in renal cell carcinoma
por: Priluck JC, et al.
Publicado: (2012)

Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Rino S. Seedor, et al.
Publicado: (2021)

Pharmacotherapy for uveitis: current management and emerging therapy
por: Barry RJ, et al.
Publicado: (2014)

Anticancer effects of mifepristone on human uveal melanoma cells
por: Prisca Bustamante Alvarez, et al.
Publicado: (2021)

Exoresection via partial lamellar sclerouvectomy approach for uveal tumors: A successful performance by a novice surgeon
por: Rengin Aslıhan Kurt, et al.
Publicado: (2010)

Current and emerging therapies for the treatment of age-related macular degeneration
por: M Vaughn Emerson, et al.
Publicado: (2008)

Conjunctival melanoma: a review of conceptual and treatment advances
por: Lim LA, et al.
Publicado: (2013)

Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973–2012)
por: Mahendraraj K, et al.
Publicado: (2016)

Uveal metastases in the mid-southeastern United States: a single-institution experience
por: King BA, et al.
Publicado: (2018)

Topical treatment options for conjunctival neoplasms
por: Jonathan W Kim, et al.
Publicado: (2008)

Uveal Melanoma Metastasis
por: Ernesto Rossi, et al.
Publicado: (2021)

Retinal vein occlusion: pathophysiology and treatment options
por: Niral Karia
Publicado: (2010)

Treatment options for ocular adnexal lymphoma (OAL)
por: Victoria Mary Lendrum Cohen
Publicado: (2009)

Optical coherence tomography findings in paraneoplastic pseudovitelliform lesions in melanoma-associated retinopathy
por: Michael Javaheri, et al.
Publicado: (2008)

Screening for Predictive Parameters Requiring Psycho-Oncological Intervention via the National Comprehensive Cancer Network Distress Thermometer in the Follow-Up of Uveal Melanoma Patients
por: Klingenstein A, et al.
Publicado: (2020)

Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics
por: Joseph S Bertino Jr
Publicado: (2009)

Clinical treatment options for patients with homonymous visual field defects
por: Alison R Lane, et al.
Publicado: (2008)

Baerveldt implant for secondary glaucoma due to iris melanoma
por: Annelie N Tan, et al.
Publicado: (2010)